Literature DB >> 23161076

Gene Regulation of Prominin-1 (CD133) in Normal and Cancerous Tissues.

Kouichi Tabu1, Norihisa Bizen, Tetsuya Taga, Shinya Tanaka.   

Abstract

A pentaspan membrane glycoprotein prominin-1 (frequently called CD133 in human) is widely used as a surface marker to identify and isolate normal stem/progenitor cells from various organs, although it is also expressed in some types of differentiated cells. Since CD133 was identified as a universal marker to isolate cancer stem cells (CSCs) in tumors derived from multiple tissues, much attention has been directed toward the relationship between its gene regulation and identity of CSCs (i.e., cancer stemness). Prominin-1 (PROM1) gene possesses five alternative promoters yielding multiple first exons within the 5'-untranslated region (UTR) and also splicing variants affecting the open reading frame (ORF) sequence, implicating the complicated gene regulation in a context-dependent manner. This chapter aims to organize the accumulated findings on prominin-1 with a focus on its altered expression and regulation in normal and cancerous cells and to discuss potential regulatory networks underlying cancer stemness.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23161076     DOI: 10.1007/978-1-4614-5894-4_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma.

Authors:  Roshan Mahabir; Mishie Tanino; Aiman Elmansuri; Lei Wang; Taichi Kimura; Tamio Itoh; Yusuke Ohba; Hiroshi Nishihara; Hiroki Shirato; Masumi Tsuda; Shinya Tanaka
Journal:  Neuro Oncol       Date:  2013-12-18       Impact factor: 12.300

2.  Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133).

Authors:  Kristina Thamm; Sylvi Graupner; Carsten Werner; Wieland B Huttner; Denis Corbeil
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.